Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.780
+0.070 (4.09%)
Nov 3, 2026, 4:00 PM EST - Market closed
Longeveron Employees
Longeveron had 38 employees as of December 31, 2025. The number of employees increased by 12 or 46.15% compared to the previous year. That makes Longeveron the 36,174th largest employer in the world and 4,969th in the United States.
Employees
38
Change (1Y)
12
Growth (1Y)
46.15%
Revenue / Employee
$31,237
Profits / Employee
-$617,737
Market Cap
5.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 12 | 46.15% | 38 | 0 |
| Dec 31, 2024 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2023 | 24 | 3 | 14.29% | 23 | 1 |
| Dec 31, 2022 | 21 | 1 | 5.00% | 19 | 2 |
| Dec 31, 2021 | 20 | 8 | 66.67% | 18 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Senti Biosciences Holdings | 39 |
| Imunon | 20 |
| Cardio Diagnostics Holdings | 17 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Pulmatrix | 2 |
LGVN News
- 6 days ago - Longeveron Announces Engagement of Lucid Capital Markets - GlobeNewsWire
- 8 days ago - Longeveron reports ELPIS II trial misses primary endpoint - TheFly
- 8 days ago - Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS) - GlobeNewsWire
- 4 weeks ago - Longeveron to Participate in Three Longevity/Aging Investment Conferences - GlobeNewsWire
- 6 weeks ago - Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial - TipRanks
- 6 weeks ago - Longeveron explores strategic options after therapy fails mid-stage trial for infant heart condition - Reuters
- 6 weeks ago - Longeveron down 55% at $2.98 after resumption of trade - TheFly
- 6 weeks ago - Longeveron Inc trading resumes - TheFly